These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 1465459)
1. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus. Ruan KS; Lilly F Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12202-6. PubMed ID: 1465459 [TBL] [Abstract][Full Text] [Related]
2. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities. Holt CA; Osorio K; Lilly F J Exp Med; 1986 Jul; 164(1):211-26. PubMed ID: 2425028 [TBL] [Abstract][Full Text] [Related]
3. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection. Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492 [TBL] [Abstract][Full Text] [Related]
4. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689 [TBL] [Abstract][Full Text] [Related]
5. Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene. Miyazawa M; Nishio J; Chesebro B J Virol; 1992 Jul; 66(7):4497-507. PubMed ID: 1534853 [TBL] [Abstract][Full Text] [Related]
6. Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv. Jones KS; Ruscetti S; Lilly F J Virol; 1988 Feb; 62(2):511-8. PubMed ID: 2826812 [TBL] [Abstract][Full Text] [Related]
7. Helper-independent mink cell focus-inducing strains of Friend murine type-C virus: potential relationship to the origin of replication-defective spleen focus-forming virus. Troxler DH; Yuan E; Linemeyer D; Ruscetti S; Scolnick EM J Exp Med; 1978 Sep; 148(3):639-53. PubMed ID: 212504 [TBL] [Abstract][Full Text] [Related]
8. Spleen focus-forming virus: specific neutralization by antisera to certain gag gene-encoded proteins. Anand R; Ruscetti S; Steeves RA; Lilly F J Virol; 1981 Jan; 37(1):55-60. PubMed ID: 6971336 [TBL] [Abstract][Full Text] [Related]
9. Fv-2 locus controls expression of Friend spleen focus-forming virus-specific sequences in normal and infected mice. Mak TW; Axelrad AA; Bernstein A Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5809-12. PubMed ID: 293685 [TBL] [Abstract][Full Text] [Related]
10. Subgenomic fragment of molecular cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease. Oliff A; Linemeyer D; Ruscetti S; Lowe R; Lowy DR; Scolnick E J Virol; 1980 Sep; 35(3):924-36. PubMed ID: 6252347 [TBL] [Abstract][Full Text] [Related]
11. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease. Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628 [TBL] [Abstract][Full Text] [Related]
12. Interference of retroviral envelope with vaccine-induced CD8 Bongard N; Lapuente D; Windmann S; Dittmer U; Tenbusch M; Bayer W Retrovirology; 2017 Apr; 14(1):28. PubMed ID: 28449719 [TBL] [Abstract][Full Text] [Related]
13. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus. Risser R J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285 [TBL] [Abstract][Full Text] [Related]
14. Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes. Ruan KS; Lilly F Virology; 1991 Mar; 181(1):91-100. PubMed ID: 1704662 [TBL] [Abstract][Full Text] [Related]
15. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity. Sugahara D; Tsuji-Kawahara S; Miyazawa M J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726 [TBL] [Abstract][Full Text] [Related]
16. A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host response. Podschwadt P; Malyshkina A; Windmann S; Werner T; Hansen W; Bayer W Retrovirology; 2022 Dec; 19(1):29. PubMed ID: 36527061 [TBL] [Abstract][Full Text] [Related]
17. Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery. Kaulfuß M; Wensing I; Windmann S; Hrycak CP; Bayer W Retrovirology; 2017 Feb; 14(1):8. PubMed ID: 28166802 [TBL] [Abstract][Full Text] [Related]
18. Augmentation of helper virus replication in the presence of defective retrovirus. Anand R; Steeves RA; Lilly F Microbios; 1989; 58(235):71-82. PubMed ID: 2544787 [TBL] [Abstract][Full Text] [Related]
19. DNA vaccine against Friend erythroleukaemia virus. Síma P; Smahel M; Jelínek F; Vonka V Folia Biol (Praha); 2002; 48(2):43-50. PubMed ID: 12002674 [TBL] [Abstract][Full Text] [Related]
20. Viral protein expression in producer and nonproducer clones of friend erythroleukemia cell lines. Anand R; Lilly F; Ruscetti S J Virol; 1981 Feb; 37(2):654-60. PubMed ID: 6938735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]